Fundraising FoxGeneseeq
Nanjing, CN · 2 known investors
Find your way into Geneseeq
Sign up to see every warm intro you have to Geneseeq
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Geneseeq team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Geneseeq develops next-generation sequencing (NGS) based genetic tests and in-vitro diagnostic products for cancer patients, using gene profiling to guide targeted drug selection, indicate drug resistance mechanisms, and monitor post-surgical recurrence. It also works on early cancer screening and provides molecular diagnostic services and pharmaceutical partnership/companion diagnostics for precision oncology.
Investors · 2
Lilly Asia Ventureslisted by Lilly Asia VenturesHong Kongvia Hongbo Lu · inferred
How we know: the VCSheet dataset · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountC roundJul 2017Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Geneseeq do?
- Geneseeq develops next-generation sequencing (NGS) based genetic tests and in-vitro diagnostic products for cancer patients, using gene profiling to guide targeted drug selection, indicate drug resistance mechanisms, and monitor post-surgical recurrence. It also works on early cancer screening and provides molecular diagnostic services and pharmaceutical partnership/companion diagnostics for precision oncology.
- Who are Geneseeq's investors?
- Geneseeq's investors include LAV, Lilly Asia Ventures.
- Where is Geneseeq headquartered?
- Geneseeq is headquartered in Nanjing, CN.